<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CatsWannaBeCats.Com | Williamson Amstrup | Activity</title>
	<link>https://www.catswannabecats.com/members/trampharbor54/activity/</link>
	<atom:link href="https://www.catswannabecats.com/members/trampharbor54/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Williamson Amstrup.</description>
	<lastBuildDate>Tue, 30 Jun 2026 07:59:13 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=7.2.0</generator>
	<language>en-CA</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">3dec5dc043e1a95ff13b14da90d9daa7</guid>
				<title>Williamson Amstrup posted an update: Over the years, botulinum toxin has found its place as a [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/23471/</link>
				<pubDate>Sun, 08 Jun 2025 09:16:38 -0400</pubDate>

									<content:encoded><![CDATA[<p>Over the years, botulinum toxin has found its place as a neuromuscular blocking agent in numerous medical fields. Since the approval of botulinum toxin by the FDA for cosmetic indications in 2002, it had become the most commonly performed esthetic procedure worldwide, with ever-growing demand. The characteristics of the toxin, along with the&hellip;<span class="activity-read-more" id="activity-read-more-23471"><a href="https://www.catswannabecats.com/activity/p/23471/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">876b8378c87f2dd9a0459f61386dea0d</guid>
				<title>Williamson Amstrup posted an update: Over the years, botulinum toxin has found its place as a [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/23382/</link>
				<pubDate>Sun, 08 Jun 2025 09:02:32 -0400</pubDate>

									<content:encoded><![CDATA[<p>Over the years, botulinum toxin has found its place as a neuromuscular blocking agent in numerous medical fields. Since the approval of botulinum toxin by the FDA for cosmetic indications in 2002, it had become the most commonly performed esthetic procedure worldwide, with ever-growing demand. The characteristics of the toxin, along with the&hellip;<span class="activity-read-more" id="activity-read-more-23382"><a href="https://www.catswannabecats.com/activity/p/23382/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">399c08f6ae2fb7d25c3a00feb40f6221</guid>
				<title>Williamson Amstrup posted an update: An NMR-based screen of a highly curated ~14 000-member f [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/10818/</link>
				<pubDate>Sun, 01 Jun 2025 03:01:54 -0400</pubDate>

									<content:encoded><![CDATA[<p>An NMR-based screen of a highly curated ~14 000-member fragment library produced 21 fragment leads. Of these, three were selected for elaboration based on structure-activity relationships generated through cycles of structural analysis by X-ray crystallography, structure-guided design principles, and synthetic chemistry. These results, combined w&hellip;<span class="activity-read-more" id="activity-read-more-10818"><a href="https://www.catswannabecats.com/activity/p/10818/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">ef957fe32175f909a2e1adc4dcc3d61c</guid>
				<title>Williamson Amstrup became a registered member</title>
				<link>https://www.catswannabecats.com/activity/p/8511/</link>
				<pubDate>Sat, 31 May 2025 21:17:06 -0400</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>